Not provided
Not provided
Not provided
Not provided
Not provided
This study was terminated early due to lack of adequate enrollment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to determine if the use of The Harmonicâ„¢ (an ultrasonic surgical instrument) in Lower Body Lift procedures reduces volume and duration of wound drainage after surgery when compared to Electro Surgery.
Lower Body Lift procedures are performed to correct skin redundancy and muscle diastases caused by significant weight loss, poor skin tone, etc. Lower Body Lift procedures involve a high risk of early complications, including hematomas, seromas, necrosis, and wound-healing problems. The occurrence of these complications may be due in part to the extensive undermining and division of the superficial and the deep arterial systems, done in conventional procedures.
Persistent serous wound drainage and seromas are the most common complications in Lower Body Lift procedures. The rate of serous fluid collection determines the time drains need to remain in place. Although suction drains reduce seroma formation, prolonged use can delay healing, cause injury, and increase the risk of retrograde infection and patient discomfort. Wound drainage has a direct correlation with seroma formation. The loss of protein nutrients and minerals in the serum drained is also a concern with prolonged drainage that can result in healing delays.
The Harmonicâ„¢ technology uses ultrasonic energy that allows both cutting and coagulating at the precise point of application. The Harmonicâ„¢ has been used since 1992 predominantly in urology and gastro-intestinal surgery (laparoscopic surgery). Significantly reduced serous drainage in a number of general surgery procedures such as superficial and total parotidectomy; thyroidectomy; tonsillectomy; pectoralis major myocutaneous flap dissection; axillary dissection; and lymphadenectomy have been reported with the use of Harmonicâ„¢.
The Harmonicâ„¢ has also been used in parotidectomy and maxillofacial surgery, but its use has been seldom mentioned in the field of plastic and reconstructive surgery. Recent use of the Harmonicâ„¢ has shown promise in plastic and reconstructive surgery in dissection of the pectoralis major myocutaneous flap and total body lifts.
Comparisons: The Harmonicâ„¢ vs. Electro Surgery in Lower Body Lift procedures.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Electro Surgery | Electro Surgical instruments are used to cut and coagulate tissue using alternating electric current at the surgical site. In Electro Surgery, the patient is included in the circuit and current enters the patient's body. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| The Harmonicâ„¢ ultrasonic scalpel | Device | A surgical instrument that uses ultrasonic energy that allows both cutting and coagulating at the precise point of application. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Total Volume (mL) From the Time of Drain Placement to Time of Drain Removal | Postoperative serous drainage volume was measured in milliliters and defined as the volume of serous fluid collected from the wound drains installed after the study procedure | From the time of drain placement to time of drain removal (</= 770 hours) |
| Measure | Description | Time Frame |
|---|---|---|
| Total Number of Hours From Drain Placement to Drain Removal | Total number of hours from drain placement to drain removal | From drain placement to drain removal (</= 770 hours) |
Not provided
Inclusion Criteria:
Subjects eligible for this clinical research study must fulfill all of the following criteria:
Exclusion Criteria:
Subjects with any of the following criteria are not eligible to participate in this clinical research study:
Not provided
Not provided
Not provided
Post massive weight loss
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Al Aly, MD | Iowa City Plastic Surgery | Principal Investigator |
| Dirk Richter, MD | Facharzt für Plastische Chirurgie | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dr. Al Aly | Coralville | Iowa | 52241 | United States | ||
| Abteilung für Plastische und Ästhetische Chirurgie |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Electro Surgery | Electro Surgical instruments are used to cut and coagulate tissue using alternating electric current at the surgical site. In Electro Surgery, the patient is included in the circuit and current enters the patient's body. |
| FG001 | Harmonic® Technology | Harmonic® Sharp Curved Blade (HF105) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instrument can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures (such as spine and joint space) and thoracic surgery. The Harmonic® Synergy™ Curved Blade (SNGCB) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instruments can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures, Ear Nose and Throat (ENT), including tissues of the soft palate, oral structures, and oropharyngeal airway, and thoracic surgery, including mobilization of the Internal Mammary Artery. These devices were not modified from their commercially available specifications. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Electro Surgery | Electro Surgical instruments are used to cut and coagulate tissue using alternating electric current at the surgical site. In Electro Surgery, the patient is included in the circuit and current enters the patient's body. |
| BG001 | Harmonic® Technology |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Total Volume (mL) From the Time of Drain Placement to Time of Drain Removal | Postoperative serous drainage volume was measured in milliliters and defined as the volume of serous fluid collected from the wound drains installed after the study procedure | ITT | Posted | Mean | Standard Deviation | milliliter | From the time of drain placement to time of drain removal (</= 770 hours) |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Electro Surgery | Electro Surgical instruments are used to cut and coagulate tissue using alternating electric current at the surgical site. In Electro Surgery, the patient is included in the circuit and current enters the patient's body. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| dyspnoea, MedDRA Version 10.0 | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| ANAEMIA ,MedDRA 10.0 | Blood and lymphatic system disorders | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Sheryl Helsinger | Ethicon Endo-Surgery | 513-337-3079 | SHelsing@its.jnj.com |
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
|
| Wesseling |
| Germany |
Harmonic® Sharp Curved Blade (HF105) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instrument can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures (such as spine and joint space) and thoracic surgery. The Harmonic® Synergy™ Curved Blade (SNGCB) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instruments can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures, Ear Nose and Throat (ENT), including tissues of the soft palate, oral structures, and oropharyngeal airway, and thoracic surgery, including mobilization of the Internal Mammary Artery. These devices were not modified from their commercially available specifications. |
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Age Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
Harmonic® Sharp Curved Blade (HF105) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instrument can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures (such as spine and joint space) and thoracic surgery.
The Harmonic® Synergy™ Curved Blade (SNGCB) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instruments can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures, Ear Nose and Throat (ENT), including tissues of the soft palate, oral structures, and oropharyngeal airway, and thoracic surgery, including mobilization of the Internal Mammary Artery.
These devices were not modified from their commercially available specifications.
|
|
| Secondary | Total Number of Hours From Drain Placement to Drain Removal | Total number of hours from drain placement to drain removal | terminated study | Posted | Mean | Standard Deviation | hours | From drain placement to drain removal (</= 770 hours) |
|
|
| 1 |
| 15 |
| 14 |
| 15 |
| EG001 | Harmonic® Technology | Harmonic® Sharp Curved Blade (HF105) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instrument can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures (such as spine and joint space) and thoracic surgery. The Harmonic® Synergy™ Curved Blade (SNGCB) instruments are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instruments can be used as an adjunct to or substitute for electrosurgery, lasers, and steel scalpels in general, plastic, gynecologic, exposure to orthopedic structures, Ear Nose and Throat (ENT), including tissues of the soft palate, oral structures, and oropharyngeal airway, and thoracic surgery, including mobilization of the Internal Mammary Artery. These devices were not modified from their commercially available specifications. | 1 | 15 | 11 | 15 |
| wound dehiscence, MedDRA 10.0 | Injury, poisoning and procedural complications | Systematic Assessment |
|
| Vertigo, MedDRA 10.0 | Ear and labyrinth disorders | Systematic Assessment |
|
| Nausea; MedDRA 10.0 | Gastrointestinal disorders | Systematic Assessment |
|
| constipations; MedDRA 10.0 | Gastrointestinal disorders | Systematic Assessment |
|
| Chills; MedDRA 10.0 | General disorders | Systematic Assessment |
|
| impaired healing; MedDRA 10.0 | General disorders | Systematic Assessment |
|
| Pyrexia; MedDRA 10.0 | General disorders | Systematic Assessment |
|
| Application site reaction; MedDRA 10.0 | General disorders | Systematic Assessment |
|
| Application site vesicles; MedDRA 10.0 | General disorders | Systematic Assessment |
|
| fatigue; MedDRA 10.0 | General disorders | Systematic Assessment |
|
| sinusitis;MedDRA 10.0 | Infections and infestations | Systematic Assessment |
|
| infection; MedDRA 10.0 | Infections and infestations | Systematic Assessment |
|
| staphyloccal infection; MedDRA 10.0 | Infections and infestations | Systematic Assessment |
|
| vaginal infection; MedDRA 10.0 | Infections and infestations | Systematic Assessment |
|
| abdominal distension; MedDRA 10.0 | Gastrointestinal disorders | Systematic Assessment |
|
| abdominal haematoma; MedDRA 10.0 | Gastrointestinal disorders | Systematic Assessment |
|
| abdominal rigidity; MedDRA 10.0 | Gastrointestinal disorders | Systematic Assessment |
|
| seroma; MedDRA 10.0 | Injury, poisoning and procedural complications | Systematic Assessment |
|
| anaemia postoperative; MedDRA 10.0 | Injury, poisoning and procedural complications | Systematic Assessment |
|
| device leakage; MedDRA 10.0 | Injury, poisoning and procedural complications | Systematic Assessment |
|
| medical device pain; MedDRA 10.0 | Injury, poisoning and procedural complications | Systematic Assessment |
|
| Post lumbar puncture syndrome; MedDRA 10.0 | Injury, poisoning and procedural complications | Systematic Assessment |
|
| procedural nausea; MedDRA 10.0 | Injury, poisoning and procedural complications | Systematic Assessment |
|
| body temperature increased; MedDRA 10.0 | Investigations | Systematic Assessment |
|
| blood pressure decreased; MedDRA 10.0 | Investigations | Systematic Assessment |
|
| lumbar puncture; MedDRA 10.0 | Investigations | Systematic Assessment |
|
| fluid retention; MedDRA 10.0 | Metabolism and nutrition disorders | Systematic Assessment |
|
| pain in extremity; MedDRA 10.0 | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| dizziness; MedDRA 10.0 | Nervous system disorders | Systematic Assessment |
|
| headache; MedDRA 10.0 | Nervous system disorders | Systematic Assessment |
|
| hypoaesthesia; MedDRA 10.0 | Nervous system disorders | Systematic Assessment |
|
| intercranial hypotension; MedDRA 10.0 | Nervous system disorders | Systematic Assessment |
|
| syncope; MedDRA 10.0 | Nervous system disorders | Systematic Assessment |
|
| anxiety; MedDRA 10.0 | Psychiatric disorders | Systematic Assessment |
|
| insomnia; MedDRA 10.0 | Psychiatric disorders | Systematic Assessment |
|
| urge incontinence; MedDRA 10.0 | Renal and urinary disorders | Systematic Assessment |
|
| perineal pain; MedDRA 10.0 | Reproductive system and breast disorders | Systematic Assessment |
|
| nasal congestion; MedDRA 10.0 | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| respiratory disorder; MedDRA 10.0 | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| pruritis; MedDRA 10.0 | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| blister; MedDRA 10.0 | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| erythema; MedDRA 10.0 | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| hypertension; MedDRA 10.0 | Vascular disorders | Systematic Assessment |
|
| ischaemia; MedDRA 10.0 | Vascular disorders | Systematic Assessment |
|
| thrombosis; MedDRA 10.0 | Vascular disorders | Systematic Assessment |
|
| Application site Excoriation, medDRA 10.0 | General disorders | Systematic Assessment |
|
| Asthenia, MedDRA 10.0 | General disorders | Systematic Assessment |
|
Sponsor has at least 60 days for review to ensure non disclosure of Confidential information. If Study is a multicenter study, PI agrees that the first publication shall include results from all PIs contributing data. If multicenter publication is not submitted within 12 months,or after Sponsor confirms there will be no multicenter Study publication, the Institution and/or such PI may publish the results from their respective site individually in accordance with this paragraph.
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |